Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

English Pharmaceutical Industries

Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx111product presentations
G46generic molecules
DF6dosage-form groups
TA4therapeutic areas
PKR111current price records
REG102registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage96%
priced packs safely normalized per unit
Comparable-market coverage91%
products with at least one like-for-like comparator
Portfolio intelligence

Therapeutic mix

Unclassified95 products · 86%
Third-generation cephalosporins7 products · 6%
Fluoroquinolone antibacterials4 products · 4%
Proton pump inhibitors3 products · 3%
HMG-CoA reductase inhibitors2 products · 2%
Formulation footprint

Dosage forms

Injection59 products
Tablet24 products
Capsule12 products
Suspension9 products
Syrup5 products
Infusion2 products
Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2323% of comparable products
Near market median52within ±5% of median
Above market median2626% of comparable products
Lowest-price equivalents11ties included
Company median price position 0.0% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Regulatory & price activity

Observed database signals

Registration numbers102
Price-history records117
Products with price history6
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date27 Jul 2026
Latest source observation9 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

111 results
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Enfal Cefazolin 500 mg Injection Vial 040130 PKR 118.00 PKR 118.00/vial/unit Near median
Enfal Cefazolin 1 g Injection Vial 040131 PKR 209.50 PKR 209.50/vial/unit Near median
Enfal Cefazolin 250 mg Injection Vial 040129 PKR 78.67 PKR 78.67/vial/unit Near median
Engmox Moxifloxacin 400 mg Tablet 5's 036144 PKR 961.00 PKR 192.20/tablet 6% above median
Engpan Meropenem 500 mg Injection 1's 064555 PKR 1,149.16 PKR 1,149.16/vial/unit 45% below median
Engsit Ondansetron 4 mg Tablet 10's 126331 PKR 1,065.68 PKR 106.57/tablet 15% above median
Engsit Ondansetron 8 mg Tablet 10's 126332 PKR 1,776.13 PKR 177.61/tablet 6% above median
Engsit Ondansetron 4 mg/5 mL Syrup 50ml 126333 PKR 1,032.63 PKR 20.65/mL 15% above median
Engsit Ondansetron 4 g/2 mL Injection 5's x2ml 126334 PKR 2,885.81 PKR 288.58/mL Near median
Engsit Ondansetron 8 g/4 mL Injection 5's x2ml 126335 PKR 5,156.19 PKR 515.62/mL Near median
Engsit Ondansetron 4 g/2 mL Injection 1's x2ml 126334 PKR 577.76 PKR 288.88/mL Near median
Engsit Ondansetron 8 g/4 mL Injection 1's x2ml 126335 PKR 1,031.24 PKR 515.62/mL Near median
Engsol Sodium chloride 0.9 % Injection 5ml 074239 PKR 18.27 PKR 3.65/mL 300% above median
Engsol W/V Sodium chloride 0.9 % Injection 10mlx100's 074238 PKR 973.76 PKR 0.97/mL 7% above median
Engsunate Artesunate 30 mg Injection 1's 092530 PKR 137.13 PKR 137.13/vial/unit Near median
Engsunate Artesunate 120 mg Injection 1's 092531 PKR 380.91 PKR 380.91/vial/unit 5% below median
Enmox Amoxicillin 250 mg Injection 10 x vial's 074334 PKR 476.13 No comparator
Enmox Amoxicillin 1000 mg Tablet 10's 023753 PKR 232.16 PKR 23.22/tablet Near median
Enmox Amoxicillin 250 mg Capsule 100's 065933 PKR 649.80 PKR 6.50/capsule 41% below median
Enmox Amoxicillin 250 mg/5 mL Suspension 60ml 026140 PKR 110.00 PKR 1.83/mL 18% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.